NINTEDANIB ESYLATE vs SIROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. NINTEDANIB ESYLATE and SIROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	NINTEDANIB ESYLATE	SIROLIMUS
Rating	New	66/100
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	NINTEDANIB ESYLATE	SIROLIMUS
Manufacturer	Dr Reddys	Apotex
Dosage forms	Capsule	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Idiopathic Pulmonary Fibrosis	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

nintedanib esylate sirolimus

Rating

New

66/100

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

NINTEDANIB ESYLATE

SIROLIMUS

Manufacturer

Dr Reddys

Apotex

Dosage forms

Capsule

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Idiopathic Pulmonary Fibrosis

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

What is the difference between Nintedanib Esylate and Sirolimus?

Nintedanib Esylate contains Nintedanib Esylate, while Sirolimus contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.